Apply on Employer Site

EyePoint · 18 hours ago

Coop Formulation Development

Watertown, MA

Full-time

Onsite

New Grad

$32/hr - $42/hr

EyePoint is an ophthalmology company committed to improving the lives of patients with serious retinal diseases by developing and commercializing innovative therapeutics. The Co-op position involves developing ocular formulations and manufacturing processes for pre-clinical and clinical use while ensuring compliance with safety regulations and laboratory best practices.

BiotechnologyHealth CareMedicalPharmaceutical

H1B Sponsor Likely

Responsibilities

Develop ocular formulations and manufacturing process for pre-clinical and clinical use

Interpret complicated data sets and provide sound recommendations

Maintain knowledge with up-to-date scientific literature in the field of ocular drug delivery

Maintain a detailed and organized laboratory notebook

Share findings in technical presentations and technical report

Build expertise and knowledge around ocular formulation drug products

Ensure compliance with safety and regulations as well as experimental/laboratory best practices

Qualification

Formulation developmentLaboratory research experiencePharmaceutical SciencesChemical EngineeringChemistryInterpersonal skillsWritten communicationVerbal communicationTeam playerCreativity

Required

Currently enrolled in a university, pursuing a graduate degree in Pharmaceutical Sciences, Chemical Engineering, Chemistry, or related discipline

Laboratory research experience (particularly formulations) is a plus (academic or industry)

Excellent team player with strong interpersonal, written and verbal communication skills

Personal Qualities: Bright, energetic, hard-working, and creative

Preferred

Prior formulation development & characterization experience is a plus

Company

EyePoint

EyePoint (Nasdaq: EYPT) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative therapeutics to improve the lives of people with serious retinal diseases.

Founded in 1987

Watertown, Massachusetts, USA

51-200 employees

http://www.eyepointpharma.com/

H1B Sponsorship

EyePoint has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)

Distribution of Different Job Fields Receiving Sponsorship

Represents job field similar to this job

Trends of Total Sponsorships

2024 (4)

2021 (1)

Funding

Current Stage

Public Company

Total Funding

$803.8M

Key Investors

Silicon Valley BankOcumension TherapeuticsEssex Woodlands Healthcare Partners

2025-10-14Post Ipo Equity· $150M

2023-12-05Post Ipo Equity· $215.9M

2022-03-09Post Ipo Debt· $45M

Leadership Team

Paul Ashton

President, Chief Executive Officer and a Director

Diane Shay

Vice President of Quality

Recent News

Clinical Trials Arena

Ollin Biosciences’ OLN324 bests Vabysmo in DME and wAMD head-to-head trial

2026-01-11

GlobeNewswire

EyePoint to Present at the 44th Annual J.P. Morgan Healthcare Conference

2025-12-17

GlobeNewswire

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

2025-12-16

Company data provided by crunchbase